Latest news
Weekly Recap: Merger talks with Bristol Myers and Imjudo launch in China - TradingViewTradingView · Mon, 10 Aug 2026 05:15:00 GMTAstraZeneca-Bristol Myers’ $400B Merger Buzz Cools After Report Denies Talks – ‘There Never Was A Deal To Be Done’ - StocktwitsStocktwits · Sat, 08 Aug 2026 09:44:55 GMTAstraZeneca, BMS not pursuing merger talks: Reuters - NJBIZNJBIZ · Thu, 06 Aug 2026 17:42:22 GMTWhat the AstraZeneca-BMS rumors reveal about pharma megamergers - Pharma VoicePharma Voice · Thu, 06 Aug 2026 13:40:22 GMTPharma Pulse: AstraZeneca-BMS Speculation Cools, Drones Land in Pharmacy, Agentic AI Hits 3PL - Pharmaceutical CommercePharmaceutical Commerce · Thu, 06 Aug 2026 13:01:55 GMTAstraZeneca may buck a decade of pharma strategy to buy U.S. scale - CNBCCNBC · Thu, 06 Aug 2026 09:40:16 GMTBristol Myers Squibb (BMY) Stock Looks Reasonable Below Fair Value - simplywall.stsimplywall.st · Thu, 06 Aug 2026 04:48:40 GMTSoriot should explain the curious case of AstraZeneca’s non-deal - The GuardianThe Guardian · Thu, 06 Aug 2026 01:30:00 GMT